Cyclophosphamide therapy in adults with minimal-change nephrotic syndrome.
D000293:Adolescent; D000328:Adult; D000568:Amenorrhea / Q000209:etiology; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008853:Microscopy; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000188:drug therapy* / Q000473:pathology / Q000652:urine; D011507:Proteinuria; D012075:Remission, Spontaneous; D012709:Serum Albumin / Q000032:analysis; D013256:Steroids / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors
D012709:Serum Albumin; D013256:Steroids; D003520:Cyclophosphamide; D002784:Cholesterol